Cas:1073371-78-4 2,6-Dichloropyridine-3-boronic acid pinacol ester manufacturer & supplier

Chemical Name:2,6-Dichloropyridine-3-boronic acid pinacol ester

CAS.NO:1073371-78-4

Synonyms:2,5-DICHLOROBENZAMIDE;QC-9651;2,6-Dichloropyridine-3-boronic acid pinacol ester

Molecular Formula:C₁₁H₁₄BCl₂NO₂

Molecular Weight:273.95100

HS Code:

Physical and Chemical Properties:

Melting point:51-53℃

Boiling point:360.3ºC at 760 mmHg

Density:1.24 g/cm3

Index of Refraction:

PSA:31.35000

Exact Mass:273.04900

LogP:2.68760

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,5-DICHLOROBENZAMIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Dichloropyridine-3-boronic acid pinacol ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QC-9651 Use and application,2,6-Dichloropyridine-3-boronic acid pinacol ester technical grade,usp/ep/jp grade.

Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 2,6-Dichloropyridine-3-boronic acid pinacol ester manufacturer Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. 2,6-Dichloropyridine-3-boronic acid pinacol ester supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 2,6-Dichloropyridine-3-boronic acid pinacol ester vendor That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 2,6-Dichloropyridine-3-boronic acid pinacol ester factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.